These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5273031)

  • 1. Experimental leukaemia chemotherapy: a perspective.
    Cain BF
    N Z Med J; 1970 Jul; 72(458):40-4. PubMed ID: 5273031
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells.
    Skipper HE; Schabel FM; Lloyd HH
    Semin Hematol; 1978 Jul; 15(3):207-19. PubMed ID: 675261
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental cancer chemotherapy: strategy for cure.
    Cain BF
    N Z Med J; 1971 Feb; 73(465):85-90. PubMed ID: 4994879
    [No Abstract]   [Full Text] [Related]  

  • 4. Perturbation of leukemic cell population in AKR mice due to chemotherapy.
    Omine M; Perry S
    Cancer Res; 1973 Nov; 33(11):2596-602. PubMed ID: 4748424
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
    Skipper HE; Schabel FM
    Cancer Chemother Rep 3; 1972 May; 3(1):3-5. PubMed ID: 4340386
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronobiology as it relates to toxicology, pharmacology, and chemotherapy.
    Scheving LE; Scheving LA; Feuers RJ; Tsai TH; Cope FO
    Regul Toxicol Pharmacol; 1993 Apr; 17(2 Pt 1):209-18. PubMed ID: 8484028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
    Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
    Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronobiology and the perspectives of its use in medicine].
    Scheving LE; Kanabrocki EL
    Postepy Hig Med Dosw; 1979; 33(3):249-62. PubMed ID: 390525
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronochemotherapy: L 1210 leukemia and beyond.
    Halberg F; Nelson W; Cornélissen G; Haus E; Scheving LE; Good RA
    Chronobiologia; 1979; 6(3):203-11. PubMed ID: 520097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.
    Skipper HE; Schabel FM; Trader MW; Laster WR
    Cancer Chemother Rep; 1969 Dec; 53(6):345-66. PubMed ID: 5384468
    [No Abstract]   [Full Text] [Related]  

  • 11. [A modified screening model for potential cancerostatics by i.v. application of L 1210 ascites cells (author's transl)].
    Fey F; Ring G
    Arch Geschwulstforsch; 1976; 46(6):461-70. PubMed ID: 999455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased life-span in AKR leukemia mice treated with prophylactic chemotherapy.
    Straus MJ; Choi SC; Goldin A
    Cancer Res; 1973 Jul; 33(7):1724-8. PubMed ID: 4721231
    [No Abstract]   [Full Text] [Related]  

  • 13. Composition of leukemic cell populations in AKR leukemia and effects of chemotherapy.
    Omine M; Sarna GP; Perry S
    Eur J Cancer (1965); 1973 Aug; 9(8):557-65. PubMed ID: 4788844
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of chemotherapy on the kinetics of leukemic cell behavior.
    Skipper HE
    Cancer Res; 1965 Oct; 25(9):1544-50. PubMed ID: 5861078
    [No Abstract]   [Full Text] [Related]  

  • 15. [The diurnal rhythm of the mitotic activity of the spleen cells of mice with leukemia and the influence of cyclophosphane on it].
    Vasil'eva VI
    Biull Eksp Biol Med; 1970 Feb; 69(2):85-7. PubMed ID: 5424247
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
    Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of cyclocytidine derivatives.
    Hoshi A; Kanazawa F; Kuretani K; Kanai T; Kikugawa K
    Gan; 1973 Oct; 64(5):519-22. PubMed ID: 4769741
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of cyclophosphane on the mitotic activity in the esophageal and corneal epithelium of leukemic mice].
    Vasil'eva VI; Mamontov SG; Bliakher MS
    Biull Eksp Biol Med; 1970 Jul; 70(7):82-5. PubMed ID: 5501780
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
    Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
    Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.